16 Prostate Cancer Clinical Trials in Myrtle Beach, SC (2026)

Q: How do I join a clinical trial in Myrtle Beach?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Myrtle Beach research site will contact you.

Recruiting Prostate Cancer Studies in Myrtle Beach

NCT07543757Recruiting

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

The study is a prospective, multi-center, single cohort study involving up to 10 urological clinics in the US. After provision of informed consent and prior to the scheduled prostate biopsy (≤30 days)...

Myrtle Beach, SC500 participantsSequenom, Inc.

View Study Details

NCT07336446Recruiting

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

ANDROMEDA is a first-in-human, Phase I/II, open-label, multicenter study of AZD9750 in participants with metastatic prostate cancer. The trial evaluates safety, tolerability, pharmacokinetics/pharmaco...

Myrtle Beach, SCPHASE1300 participantsAstraZeneca

View Study Details

NCT07005154Recruiting

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to treat prostate cancer. It works by reducing the amount of the main male sex hormone, testosterone in the body. Androgen rece...

Myrtle Beach, SCPHASE2218 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT06800313Recruiting

A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Assessment of the safety and efficacy of HLD-0915 as monotherapy in patients with metastatic castration resistant prostate cancer (mCRPC) that have progressed on prior systemic therapies, once a recom...

Myrtle Beach, SCPHASE1190 participantsHalda Therapeutics OpCo, Inc.

View Study Details

NCT07190300Recruiting

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

The purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone...

Myrtle Beach, SCPHASE1181 participantsNovartis Pharmaceuticals

View Study Details

NCT07181161Recruiting

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treatment of metastatic prostate cancer....

Myrtle Beach, SCPHASE1177 participantsAstraZeneca

View Study Details

NCT07103018Recruiting

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Study K36-MCRPC-001 is the first in human clinical trial testing KTX-2001 alone and with darolutamide in men with metastatic castration-resistant prostate cancer. The study aims to assess whether the ...

Myrtle Beach, SCPHASE1144 participantsK36 Therapeutics, Inc.

View Study Details

NCT07287150Recruiting

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

This study will evaluate the efficacy and safety of the combination of inavolisib plus enzalutamide compared with physician's choice of alternative androgen receptor pathway inhibitor (ARPi) or doceta...

Myrtle Beach, SCPHASE2100 participantsHoffmann-La Roche

View Study Details

NCT06636682Recruiting

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

The goal of this clinical trial is to learn if the vaccine FK-PC101 works to delay or prevent the return of prostate cancer in men who have had surgery to remove their prostate cancer. It will also le...

Myrtle Beach, SCPHASE2100 participantsCellvax Therapeutics Inc

View Study Details

NCT06801236Recruiting

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

This is an open label, phase I, multi-center study aiming to assess the safety and tolerability in patients with metastatic castration resistant prostate cancer (mCRPC)....

Myrtle Beach, SCPHASE167 participantsAcerand Therapeutics (Hong Kong) Limited

View Study Details

NCT07719361Recruiting

A Phase 1 Study in Patients With Metastatic Castration-Resistant Prostate Cancer

The goal of this clinical trial is to find out if FX-111 is safe enough to permit further studies in adult male participants with metastatic castration-resistant prostate cancer (mCRPC). It will also ...

Myrtle Beach, SCPHASE160 participantsFlare Therapeutics Inc.

View Study Details

NCT07140900Recruiting

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

The main objective of the trial is to evaluate the safety and tolerability of xaluritamig in combination with darolutamide or abiraterone....

Myrtle Beach, SCPHASE160 participantsAmgen

View Study Details

NCT07244341Recruiting

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

This study will assess the safety and tolerability of valemetostat in combination with darolutamide in participants with Metastatic Castration Resistant Prostate Cancer (mCRPC)....

Myrtle Beach, SCPHASE160 participantsDaiichi Sankyo

View Study Details

NCT06257693Recruiting

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy....

Myrtle Beach, SCPHASE156 participantsAlessa Therapeutics Inc.

View Study Details

NCT07332000Recruiting

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Phase 2a, open-label, multi-center study evaluating biomarkers and biodistribution of aglatimagene besadenovec plus valacyclovir in men with localized, intermediate-risk prostate cancer who are planni...

Myrtle Beach, SCPHASE245 participantsCandel Therapeutics, Inc.

View Study Details

NCT06613100Recruiting

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

The primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered as monotherapy or in combination with an oral Gonadotropin-releasing Hormone (GnRH) antagon...

Myrtle Beach, SCPHASE140 participantsAmgen

View Study Details

About Prostate Cancer Clinical Trials in Myrtle Beach

Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.

There are currently 16 prostate cancer clinical trials recruiting participants in Myrtle Beach, SC. These studies are seeking a combined 2,298 participants. Research is being sponsored by Sequenom, Inc., AstraZeneca, Astellas Pharma Global Development, Inc. and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prostate Cancer Clinical Trials in Myrtle Beach — FAQ

Are there prostate cancer clinical trials in Myrtle Beach?

Yes, there are 16 prostate cancer clinical trials currently recruiting in Myrtle Beach, SC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Myrtle Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Myrtle Beach research site will contact you about next steps.

Are clinical trials in Myrtle Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Myrtle Beach studies also compensate for your time and travel.

What prostate cancer treatments are being tested?

The 16 active trials in Myrtle Beach are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.

Data updated July 22, 2026 from ClinicalTrials.gov